Studies have reported that ZBTB7A plays both proto-oncogenic and tumor suppressive roles that depend on the cancer type and stage-specific situation and that targeting ZBTB7A could be a promising tumor growth inhibition approach [39–44]. This evidence concerns the gene ZBTB7A and cancer.